よむ、つかう、まなぶ。
05参考資料 帯状疱疹ワクチンファクトシート第二版［3.2MB］ (73 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_47466.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会（第65回 12／18）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 1994; 330(13):
896-900.
93.
McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in
neuropathic pain. Pain 1996; 68(2-3): 217-27.
94.
Winston DJ, Mullane KM, Cornely OA, et al. Inactivated varicella zoster vaccine in autologous haemopoietic stemcell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet
2018; 391(10135): 2116-27.
95.
Mullane KM, Morrison VA, Camacho LH, et al. Safety and efficacy of inactivated varicella zoster virus vaccine in
immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial. Lancet Infect
Dis 2019; 19(9): 1001-12.
96.
Uda K, Okubo Y, Tsuge M, Tsukahara H, Miyairi I. Impacts of routine varicella vaccination program and COVID19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan. Vaccine
2023; 41(34): 4958-66.
97.
Ishimaru S, Michihata N, Kawamura Y, et al. Trend in the Numbers of Hospitalized Patients With Varicella, Herpes
Zoster, and Ischemic Stroke in Japanese Individuals <20 Years of Age Before and After Implementation of Universal
Varicella Vaccination. Pediatr Infect Dis J 2023; 42(7): 626-8.
98.
外山望. 帯状疱疹大規模疫学調査「宮崎スタディ（1997-2017）
」アップデート. 病原微生物検出情報
IASR 2018; 39(2018 年 8 月号): 139-41.
99.
Shiraki K, Toyama N, Tanaka K, Ito A, Yamamoto J, members of the Miyazaki Dermatologist S. Effect of universal
varicella vaccination and behavioral changes against coronavirus disease 2019 pandemic on the incidence of herpes
zoster. J Dermatol Sci 2021; 104(3): 185-92.
100.
白木公康, 外山望. 帯状疱疹の宮崎スタディ. モダンメディア 2020; 66(9): 251-164.
101.
Kawahira K, Imano H, Yamada K, et al. Risk of herpes zoster according to past history in the general population:
The Japanese Shozu herpes zoster study. J Dermatol 2023; 50(9): 1140-4.
102.
Kim YJ, Lee CN, Lim CY, Jeon WS, Park YM. Population-based study of the epidemiology of herpes zoster in
Korea. J Korean Med Sci 2014; 29(12): 1706-10.
103.
Choi JK, Park SH, Park S, et al. The changing epidemiology of herpes zoster over a decade in South Korea, 20062015. Vaccine 2019; 37(36): 5153-60.
104.
Gialloreti LE, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic
neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010; 10: 230.
105.
Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Annual incidence rates of herpes zoster
among an immunocompetent population in the United States. BMC Infect Dis 2015; 15: 502.
106.
Pham MA, Bednarczyk RA, Becker ER, Orenstein WA, Omer SB. Trends in U.S. Community hospitalizations due
to herpes zoster: 2001-2015. Vaccine 2019; 37(6): 882-8.
107.
Morant-Talamante N, Diez-Domingo J, Martínez-Úbeda S, Puig-Barberá J, Alemán-Sánchez S, Pérez-Breva L.
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). BMC Infect Dis 2013;
13: 463.
108.
Masa-Calles J, Lopez-Perea N, Vila Cordero B, Carmona R. [Surveillance and epidemiology of Herpes Zoster in
71
896-900.
93.
McQuay HJ, Tramèr M, Nye BA, Carroll D, Wiffen PJ, Moore RA. A systematic review of antidepressants in
neuropathic pain. Pain 1996; 68(2-3): 217-27.
94.
Winston DJ, Mullane KM, Cornely OA, et al. Inactivated varicella zoster vaccine in autologous haemopoietic stemcell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet
2018; 391(10135): 2116-27.
95.
Mullane KM, Morrison VA, Camacho LH, et al. Safety and efficacy of inactivated varicella zoster virus vaccine in
immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial. Lancet Infect
Dis 2019; 19(9): 1001-12.
96.
Uda K, Okubo Y, Tsuge M, Tsukahara H, Miyairi I. Impacts of routine varicella vaccination program and COVID19 pandemic on varicella and herpes zoster incidence and health resource use among children in Japan. Vaccine
2023; 41(34): 4958-66.
97.
Ishimaru S, Michihata N, Kawamura Y, et al. Trend in the Numbers of Hospitalized Patients With Varicella, Herpes
Zoster, and Ischemic Stroke in Japanese Individuals <20 Years of Age Before and After Implementation of Universal
Varicella Vaccination. Pediatr Infect Dis J 2023; 42(7): 626-8.
98.
外山望. 帯状疱疹大規模疫学調査「宮崎スタディ（1997-2017）
」アップデート. 病原微生物検出情報
IASR 2018; 39(2018 年 8 月号): 139-41.
99.
Shiraki K, Toyama N, Tanaka K, Ito A, Yamamoto J, members of the Miyazaki Dermatologist S. Effect of universal
varicella vaccination and behavioral changes against coronavirus disease 2019 pandemic on the incidence of herpes
zoster. J Dermatol Sci 2021; 104(3): 185-92.
100.
白木公康, 外山望. 帯状疱疹の宮崎スタディ. モダンメディア 2020; 66(9): 251-164.
101.
Kawahira K, Imano H, Yamada K, et al. Risk of herpes zoster according to past history in the general population:
The Japanese Shozu herpes zoster study. J Dermatol 2023; 50(9): 1140-4.
102.
Kim YJ, Lee CN, Lim CY, Jeon WS, Park YM. Population-based study of the epidemiology of herpes zoster in
Korea. J Korean Med Sci 2014; 29(12): 1706-10.
103.
Choi JK, Park SH, Park S, et al. The changing epidemiology of herpes zoster over a decade in South Korea, 20062015. Vaccine 2019; 37(36): 5153-60.
104.
Gialloreti LE, Merito M, Pezzotti P, et al. Epidemiology and economic burden of herpes zoster and post-herpetic
neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010; 10: 230.
105.
Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Annual incidence rates of herpes zoster
among an immunocompetent population in the United States. BMC Infect Dis 2015; 15: 502.
106.
Pham MA, Bednarczyk RA, Becker ER, Orenstein WA, Omer SB. Trends in U.S. Community hospitalizations due
to herpes zoster: 2001-2015. Vaccine 2019; 37(6): 882-8.
107.
Morant-Talamante N, Diez-Domingo J, Martínez-Úbeda S, Puig-Barberá J, Alemán-Sánchez S, Pérez-Breva L.
Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). BMC Infect Dis 2013;
13: 463.
108.
Masa-Calles J, Lopez-Perea N, Vila Cordero B, Carmona R. [Surveillance and epidemiology of Herpes Zoster in
71